Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 42.90M | £ 19.50M | £ 11.10M | £ 67.10M | £ 85.40M |
Total Assets | £ 503.60M | £ 549.20M | £ 546.00M | £ 615.70M | £ 584.70M |
Total Debt | £ 145.20M | £ 153.60M | £ 113.30M | £ 95.30M | £ 106.10M |
Net Debt | £ 102.30M | £ 134.10M | £ 102.20M | £ 28.20M | £ 20.70M |
Total Liabilities | £ 417.20M | £ 476.80M | £ 455.90M | £ 519.30M | £ 489.80M |
Stockholders Equity | £ 87.30M | £ 73.40M | £ 91.40M | £ 97.70M | £ 96.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |